Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03416179
Title A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (BRIGHT AML1019)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer

acute myeloid leukemia



Cytarabine + Daunorubicin + Glasdegib

Azacitidine + Glasdegib


Cytarabine + Daunorubicin

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT

No variant requirements are available.